Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/201322
Type: Artigo de periódico
Title: Prophylactic Use Of Ketorolac Tromethamine In Cataract Surgery: A Randomized Trial.
Author: Ticly, Flavia G
Lira, Rodrigo P C
Zanetti, Fernando R
Machado, Maria Cecília
Rodrigues, Gustavo B
Arieta, Carlos Eduardo L
Abstract: To determine the efficacy of topical ketorolac tromethamine in preventing cystoid macular edema (CME) after uncomplicated cataract surgery. This single-center, prospective, double-masked, randomized clinical trial consisted of 81 patients who were scheduled for cataract surgery. Patients were randomized to receive hypromellose/dextran 70 as a placebo (n=44) or ketorolac tromethamine 0.4% (n=37) as an adjuvant therapy. These eye drops were administered 4 times daily (QID) for 3 days before surgery and 5 weeks postoperatively. All patients received prednisolone acetate 1% QID during the same period as basal/standard anti-inflammatory therapy. The primary outcome was the incidence of angiographic CME 5 weeks after surgery. The secondary outcomes were mean change in best-corrected visual acuity (BCVA) [Early Treatment Diabetic Retinopathy study (ETDRS)], clinical CME incidence, intraocular pressure, and retinal thickness measured using optical coherence tomography (OCT). In the placebo group, 2/44 (4.5%) patients and in the ketorolac group, 2/37 (5.4%) patients presented with angiographic CME (P=0.624). The mean change in postoperative BCVA was 32±15 letters in the placebo group and 26±16 letters in the ketorolac group (P=0.07). There were no statistically significant between-group differences in the mean central subfield thickness (P=0.679), minimal central thickness (P=0.352), or central macular volume (P=0.729). There was no difference between ketorolac tromethamine and a placebo with regard to BCVA results or prevention of CME after uncomplicated cataract surgery.
Subject: Aged
Anti-inflammatory Agents
Anti-inflammatory Agents, Non-steroidal
Cataract Extraction
Double-blind Method
Female
Follow-up Studies
Humans
Ketorolac Tromethamine
Macular Edema
Male
Middle Aged
Ophthalmic Solutions
Prednisolone
Prospective Studies
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity
Rights: fechado
Identifier DOI: 10.1089/jop.2013.0214
Address: http://www.ncbi.nlm.nih.gov/pubmed/24735005
Date Issue: 2014
Appears in Collections:Artigos e Materiais de Revistas Científicas - Unicamp

Files in This Item:
File SizeFormat 
pmed_24735005.pdf323.89 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.